Page 1 of Clinical Trials for Drug rifampin, 195 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Withdrawn
Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)
Last Updated: February 22, 2011
Condition(s): Healthy
2
Active, not recruiting
Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions
Last Updated: November 12, 2009
Condition(s): Adverse Drug Interactions
3
Completed
TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.
Last Updated: April 26, 2010
Condition(s): Hepatitis C; HCV; Tuberculosis; Rifampin; Pharmacokinetics
4
Completed
Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.
Last Updated: March 20, 2012
Condition(s): Healthy
5
Not yet recruiting
Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin
Last Updated: May 21, 2012
Condition(s): Tuberculosis
6
Active, not recruiting
Randomized Clinical Trial of 4RIF vs. 9INH for the Treatment of Latent TB - Safety
Last Updated: July 22, 2011
Condition(s): Latent Tuberculosis Infection
7
Recruiting
A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast
Last Updated: March 22, 2012
Condition(s): Healthy
8
Completed
A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults
Last Updated: May 9, 2012
Condition(s): Healthy Volunteers
9
Completed
Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis
Last Updated: December 3, 2010
Condition(s): HIV Infections; Tuberculosis
10
Not yet recruiting
Trial of High-Dose Rifampin in Patients With TB
Last Updated: August 2, 2011
Condition(s): Tuberculosis
11
Active, not recruiting
Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
Last Updated: December 3, 2010
Condition(s): HIV Infections; Tuberculosis
12
Recruiting
Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity
Last Updated: February 14, 2012
Condition(s): Hepatitis; Tuberculosis
13
Completed
A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
Last Updated: March 29, 2012
Condition(s): Mycobacterium Avium-intracellulare Infection; HIV Infections
14
Completed
Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)
Last Updated: June 9, 2011
Condition(s): Tuberculosis
15
Recruiting
Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118
Last Updated: March 19, 2012
Condition(s): Drug Induced Constipation
16
Active, not recruiting
Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
Last Updated: September 15, 2011
Condition(s): Opioid Dependency; HIV Infections
17
Completed
Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults
Last Updated: May 17, 2012
Condition(s): HIV Infections; Tuberculosis
18
Completed
Drug-Drug Interaction Study With Rifampin
Last Updated: January 24, 2011
Condition(s): Alzheimer Disease
19
Recruiting
Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis
Last Updated: January 27, 2012
Condition(s): Pulmonary Tuberculosis
20
Completed
Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
Last Updated: March 1, 2011
Condition(s): HIV Infections; Tuberculosis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+rifampin

Page 1 of Clinical Trials for Drug rifampin, 195 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About